Partners Value Investments L.P.Partners Value Investments L.P.

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

BROOKFIELD CORP /CAD/

181.4M$8.3B77.8%$29.12+58.94%
10 qtrssince 2023-Q3
Increased
89

BROOKFIELD ASSET MGMT-A-W/I

30.8M$1.6B15.1%$30.97+70.16%
10 qtrssince 2023-Q3
Unchanged
0

BROOKFIELD WEALTH SOL LTD

12.3M$566.1M5.3%$39.08+19.16%
6 qtrssince 2024-Q3
Increased
88
BBUBBU
Unit

BROOKFIELD BUSINESS PARTNERS

4.4M$156.6M1.5%$18.47+85.61%
28 qtrssince 2017-Q1
Unchanged
0

BROOKFIELD BUSINESS CORP

757,259$27.2M0.3%$23.04+25.65%
5 qtrssince 2024-Q4
Unchanged
0

META PLATFORMS INC-CLASS A

11,619$7.7M0.1%$732.54-9.09%
3 qtrssince 2025-Q2
Unchanged
0

ALPHABET INC-CL C

22,500$7.1M0.1%$177.99+76.72%
3 qtrssince 2025-Q2
Decreased
0
$10.7B
AUM
7
Positions
Q4 2025
Filing
Rating · 3.5
Quarterly Portfolio Change
+27%Q3'24$8.5B+9%Q4'24$9.2B-9%Q1'25$8.4B+18%Q2'25$9.9B+9%Q3'25$10.8B-1%Q4'25$10.7B
Activity profile
$ moved · Q4'25
New0%Increased90%Decreased10%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 years
<1Q0%1-4Q29%1-2Y14%2Y+57%

Partners Value Investments L.P. manages $10.7B across 7 positions as of Q4 2025. Top holdings: BN (77.8%), BAM (15.1%), BNT (5.3%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 3.5/5.0.

Q4 2025 Summary

Increased 2, trimmed 1. Top move: BN (INCREASED, conviction 89). Portfolio: $10.7B across 7 positions.

Top holdings by portfolio weight

Total AUM$11B
BN77.78%
BAM15.07%
BNT5.29%
BBU1.46%
BBUC0.25%
META0.07%
GOOG0.07%

Portfolio allocation by GICS sector

Sectors3
Financial Services98.40%
Industrials1.46%
Communication Services0.14%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record74
Conviction40
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used